APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 262 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $72,500 | -99.9% | 100,000 | -87.7% | 0.00% | -99.9% |
| Q2 2023 | $73,976,570 | +102.0% | 812,037 | +46.2% | 2.14% | +97.9% |
| Q1 2023 | $36,630,490 | +46.4% | 555,344 | +51.6% | 1.08% | +49.0% |
| Q3 2022 | $25,025,000 | +72.2% | 366,400 | +14.0% | 0.73% | +59.6% |
| Q2 2022 | $14,529,000 | -80.7% | 321,300 | -78.3% | 0.46% | -69.8% |
| Q1 2022 | $75,285,000 | -45.2% | 1,481,700 | -49.0% | 1.51% | +42.4% |
| Q4 2021 | $137,272,000 | +577.2% | 2,903,400 | +372.1% | 1.06% | +260.2% |
| Q3 2021 | $20,270,000 | -75.7% | 615,000 | -53.5% | 0.29% | -45.9% |
| Q2 2021 | $83,570,000 | +22304.8% | 1,322,324 | +11481.0% | 0.54% | +8950.0% |
| Q2 2020 | $373,000 | +14.1% | 11,418 | 0.0% | 0.01% | -33.3% |
| Q1 2020 | $327,000 | – | 11,418 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |